These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 8113970)

  • 41. Opioid effects on [3H]norepinephrine release from dissociated embryonic locus coeruleus cell cultures.
    Raymon HK; Leslie FM
    J Neurochem; 1994 Mar; 62(3):1015-24. PubMed ID: 8113788
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Separation of mu-opioid receptor desensitization and internalization: endogenous receptors in primary neuronal cultures.
    Arttamangkul S; Torrecilla M; Kobayashi K; Okano H; Williams JT
    J Neurosci; 2006 Apr; 26(15):4118-25. PubMed ID: 16611829
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dual inhibitory action of enadoline (CI977) on release of amino acids in the rat hippocampus.
    Millan MH; Chapman AG; Meldrum BS
    Eur J Pharmacol; 1995 Jun; 279(1):75-81. PubMed ID: 7556386
    [TBL] [Abstract][Full Text] [Related]  

  • 44. κ-Opioid receptor inhibition of calcium oscillations in spinal cord neurons.
    Kelamangalath L; Dravid SM; George J; Aldrich JV; Murray TF
    Mol Pharmacol; 2011 Jun; 79(6):1061-71. PubMed ID: 21422300
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Desensitization and trafficking of μ-opioid receptors in locus ceruleus neurons: modulation by kinases.
    Arttamangkul S; Lau EK; Lu HW; Williams JT
    Mol Pharmacol; 2012 Mar; 81(3):348-55. PubMed ID: 22113080
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Resolution and absolute configuration of an ergoline-related dopamine agonist, trans-4,4a,5,6,7,8,8a,9-Octahydro-5-propyl-1H(or 2H)-pyrazolo[3,4-g]quinoline.
    Titus RD; Kornfeld EC; Jones ND; Clemens JA; Smalstig EB; Fuller RW; Hahn RA; Hynes MD; Mason NR; Wong DT; Foreman MM
    J Med Chem; 1983 Aug; 26(8):1112-6. PubMed ID: 6876078
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Opioid receptors: drivers to addiction?
    Darcq E; Kieffer BL
    Nat Rev Neurosci; 2018 Aug; 19(8):499-514. PubMed ID: 29934561
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neurons in the monoaminergic nuclei of the rat and human central nervous system express FA1/dlk.
    Jensen CH; Meyer M; Schroder HD; Kliem A; Zimmer J; Teisner B
    Neuroreport; 2001 Dec; 12(18):3959-63. PubMed ID: 11742219
    [TBL] [Abstract][Full Text] [Related]  

  • 49. To be or not to be--obese.
    Maudsley S; Martin B; Egan JM
    Endocrinology; 2011 Oct; 152(10):3592-6. PubMed ID: 21937750
    [No Abstract]   [Full Text] [Related]  

  • 50. Effects of dysthyroidism on central catecholaminergic neurons.
    Puymirat J
    Neurochem Int; 1985; 7(6):969-77. PubMed ID: 20493009
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Selective association of embryonic murine mesencephalic dopamine neurons in vitro.
    Hemmendinger LM; Garber BB; Hoffmann PC; Heller A
    Brain Res; 1981 Oct; 222(2):417-22. PubMed ID: 7284789
    [No Abstract]   [Full Text] [Related]  

  • 52. Why do men and women feel and react to pain differently? Research suggests men and women may not process pain signals the same way.
    Bradbury J
    Lancet; 2003 Jun; 361(9374):2052-3. PubMed ID: 12814722
    [No Abstract]   [Full Text] [Related]  

  • 53. Activators of G-protein signaling 3: a drug addiction molecular gateway.
    Bowers MS
    Behav Pharmacol; 2010 Sep; 21(5-6):500-13. PubMed ID: 20700046
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of acute and repeated administration of salvinorin A on dopamine function in the rat dorsal striatum.
    Gehrke BJ; Chefer VI; Shippenberg TS
    Psychopharmacology (Berl); 2008 Apr; 197(3):509-17. PubMed ID: 18246329
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Morphine-induced increase in D-1 receptor regulated signal transduction in rat striatal neurons and its facilitation by glucocorticoid receptor activation: possible role in behavioral sensitization.
    Schoffelmeer AN; Voorn P; Jonker AJ; Wardeh G; Nestby P; Vanderschuren LJ; De Vries TJ; Mulder AH; Tjon GH
    Neurochem Res; 1996 Nov; 21(11):1417-23. PubMed ID: 8947932
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chronic activation of mu- and kappa-opioid receptors in cultured catecholaminergic neurons from rat brain causes neuronal supersensitivity without receptor desensitization.
    Ronken E; Mulder AH; Schoffelmeer AN
    J Pharmacol Exp Ther; 1994 Feb; 268(2):595-9. PubMed ID: 8113970
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Opioid receptor-mediated inhibition of evoked catecholamine release from cultured neurons of rat ventral mesencephalon and locus coeruleus.
    Ronken E; Van Muiswinkel FL; Mulder AH; Schoffelmeer AN
    Eur J Pharmacol; 1993 Jan; 230(3):349-55. PubMed ID: 8095023
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dopamine D-2 autoreceptors regulating the release of dopamine from cultured rat fetal dopaminergic neurons do not desensitize upon sustained activation: implications for the combined pharmaco- and grafting therapy in parkinsonian patients.
    Van Muiswinkel FL; Drukarch B; Steinbusch HW; Stoof JC
    Exp Neurol; 1994 Feb; 125(2):218-27. PubMed ID: 7906226
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
    Capasso A; Sorrentino L
    Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mu- and delta-opioid receptor-mediated inhibition of adenylate cyclase activity stimulated by released endogenous dopamine in rat neostriatal slices; demonstration of potent delta-agonist activity of bremazocine.
    Heijna MH; Hogenboom F; Portoghese PS; Mulder AH; Schoffelmeer AN
    J Pharmacol Exp Ther; 1989 Jun; 249(3):864-8. PubMed ID: 2543814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.